The blood-brain barrier protects the brain from poisons but also prevents drugs from reaching brain tumors; innovative new treatments are needed.
This laboratory study shows that a nanotechnology drug called SapC-DOPS crosses that barrier and targets brain-tumor cells and retards growth of tumor blood vessels. The findings also show how the agent targets tumor cells and recommend its further development as a novel treatment for glioblastoma.
An experimental drug in early development for aggressive brain tumors can cross the blood-brain tumor barrier, kill tumor cells and block the growth of tumor blood vessels, according to a study led by researchers at the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James).
The laboratory and animal study also shows how the agent, called SapC-DOPS, targets tumor cells and blood vessels. The findings support further development of the drug as a novel treatment for brain tumors.
Glioblastoma multiforme is the most common and aggressive form of brain cancer, with a median survival of about 15 months. A major obstacle to improving treatment for the 3,470 cases of the disease expected in the United States this year is the blood-brain barrier, the name given to the tight fit of cells that make up the blood vessels in the brain. That barrier protects the brain from toxins in the blood but also keeps drugs in the bloodstream from reaching brain tumors.
“Few drugs have the capacity to cross the tumor blood-brain barrier and specifically target tumor cells,” says principal investigator Balveen Kaur, PhD, associate professor of neurological surgery and chief of the Dardinger Laboratory of Neurosciences at the OSUCCC – James. “Our preclinical study indicates that SapC-DOPS does both and inhibits the growth of new tumor blood vessels, suggesting that this agent could one day be an important treatment for glioblastoma and other solid tumors.”
The findings were published in a recent issue of the journal Molecular Therapy.
SapC-DOPS (saposin-C dioleoylphosphatidylserine), is a nanovesicle drug that has shown activity in glioblastoma, pancreatic cancer and other solid tumors in preclinical studies. The nanovesicles fuse with tumor cells, causing them to self-destruct by apoptosis.
Key findings of the study, which used two brain-tumor models, include:
The Latest Bing News on:
SapC-DOPS
- AO Smithon May 1, 2024 at 5:00 pm
Digit.in is one of the most trusted and popular technology media portals in India. At Digit it is our goal to help Indian technology users decide what tech products they should buy. We do this by ...
- DMW bans seafarers on Red Sea, Gulf of Adenon April 24, 2024 at 10:39 am
The affirmation letter executed by manning agencies with the seafarers' consent must be uploaded to the DMW's Online Processing System for Sea-based (DOPS-Sea) together with the processed Standard ...
- Police detain Yahaya Bello’s ADC, security detailson April 19, 2024 at 4:59 pm
Former security aides may face orderly room trial for not arresting ex-gov EFCC appeals order stopping Bello’s arrest, seeks stay of execution The Nigeria Police Force has detained a female ...
- Will Nikita Kucherov be suspended for his hit on Kaiden Guhle? NHL insider provides latest updateon April 5, 2024 at 12:49 pm
The Department of Player Safety (DoPS) has been vigilant in addressing dangerous plays, and Kucherov's hit on Guhle is likely to come under scrutiny. NHL insider Eric Engels' fresh update hints ...
- "Take more beatings now than I did on ice": DoPS senior VP George Parros on the pressure faced from his most recent suspensionson March 20, 2024 at 8:16 am
It's a great chance for us to get together on the same page. Parros has been leading the department for seven years. He assured GMs that the DoPS is committed to ensuring player safety in the NHL.
- The Dopson January 5, 2023 at 11:48 pm
Arrived Homes is an alternative investment platform that allows individuals to easily invest in real estate by purchasing shares of rental properties. Investors on the platform earn passive income ...
- Academic Senateon June 12, 2022 at 10:20 am
Academic Policies Committee (APC) - Becky Krakowski Faculty Affairs Committee (FAC) - Andrea Seielstad Student Academic Policies Committee (SAPC) - Daniel Birdsong ...
- Six tips to better understand supplemental discipline in the NHLon October 16, 2016 at 5:00 pm
That couldn't be further from the truth, however. During the 2014-15 season I visited the NHL DOPS war room and learned everything I could about how suspensions happen. I've spent the next couple ...
- How suspensions happen: THN goes inside the NHL player safety war roomon April 4, 2015 at 5:00 pm
Whereas most members of the DOPS, from Quintal to Brian Leetch to Chris Pronger to Pat LaFontaine, come from a playing background, and Burke’s family roots tie to the game, Echevarrieta climbed ...
The Latest Google Headlines on:
SapC-DOPS
[google_news title=”” keyword=”SapC-DOPS” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
The Latest Bing News on:
Nanotechnology drug
- UQ's AMTAR hub advances the development of hyper-accurate cancer drugson May 7, 2024 at 9:01 pm
The Australian Research Council (ARC) hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR) is a one-stop-shop connecting biotech firms with expertise and equipment to design, test and ...
- Breakthrough Nanoparticle Targets Breast Cancer and Brain Tumorson May 7, 2024 at 9:04 am
In a recent study published in Proceedings of the National Academy of Sciences, scientists at the University of Miami Miller School of Medicine's Sylvester Comprehensive Cancer Center developed a ...
- Nanoparticle researchers develop microfluidic platform for better delivery of gene therapy for lung diseaseon May 7, 2024 at 7:14 am
Drug delivery researchers at Oregon State University have developed a device with the potential to improve gene therapy for patients with inherited lung diseases such as cystic fibrosis.
- Nanotechnology in Therapeuticson May 6, 2024 at 4:59 pm
Ubiquitously targeting cells within a tumor is not always feasible because some drugs cannot diffuse efficiently, and the random nature of the approach makes it difficult to control the process.
- Nanotechnology in Therapeuticson May 6, 2024 at 4:59 pm
Although progress in the application of nanotechnology to drug delivery has been dramatic and successful, as evidenced by some nanodrugs now on the market, several main challenges remain in this ...
- Nose-to-brain drug delivery by HS15 micelles for brain targeting of insoluble drugon May 4, 2024 at 5:00 pm
Announcing a new publication for Acta Materia Medica journal. Agomelatine (AGO) is an antidepressant with limited clinical application due to its low bioavailability caused by poor water solubility, ...
- Nanotubes, nanoparticles and antibodies detect tiny amounts of fentanylon May 2, 2024 at 1:22 pm
A research team at the University of Pittsburgh led by Alexander Star, a chemistry professor in the Kenneth P. Dietrich School of Arts and Sciences, has developed a fentanyl sensor that is six orders ...
- Cow's milk particles unlock one of medicine’s most challenging puzzleson April 26, 2024 at 12:47 am
Cow’s milk contains nanoparticles that can be used to deliver disease-modifying RNA therapy orally, according to a new study. With RNA-based drugs currently only administrable by injection, the ...
- Nanotechnology Drug Delivery Market To Reach USD 407.8 Billion By 2032 | DataHorizzon Researchon April 10, 2024 at 11:01 pm
Growth in chronic diseases to propel the nanotechnology drug delivery market. The rise in chronic diseases such as cancer, cardiovascular ailments, diabetes, and neurological disorders serves as a ...
- Polymeric Nanoparticles: Versatile Carriers for Drug Delivery and Beyondon April 10, 2024 at 9:19 am
These nanoparticles have gained significant attention due to their versatility, biocompatibility, and ability to encapsulate and deliver various active ingredients, such as drugs, proteins, and ...
The Latest Google Headlines on:
Nanotechnology drug
[google_news title=”” keyword=”nanotechnology drug” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]